Literature DB >> 11961185

Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis.

M J Leckie, R G Rees.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961185     DOI: 10.1093/rheumatology/41.4.473

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  Hydroxychloroquine-Induced Erythema Multiforme.

Authors:  Nour Abou Assalie; Robert Durcan; Laura Durcan; Michelle A Petri
Journal:  J Clin Rheumatol       Date:  2017-03       Impact factor: 3.517

Review 2.  Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.

Authors:  David N Juurlink
Journal:  CMAJ       Date:  2020-04-08       Impact factor: 8.262

Review 3.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

4.  Hydroxychloroquine-induced Stevens-Johnson syndrome in COVID-19: a rare case report.

Authors:  Lotfollah Davoodi; Hamed Jafarpour; Armaghan Kazeminejad; Eissa Soleymani; Zahra Akbari; Alireza Razavi
Journal:  Oxf Med Case Reports       Date:  2020-06-25

Review 5.  Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity.

Authors:  Siya Kamat; Madhuree Kumari
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

6.  [Drug-induced toxidermia in a patient receiving hydroxychloroquine as systemic therapy for primary Gougerot-Sjögren syndrome: a case report].

Authors:  Ansumana Mohammed Keita; Mouna Zahlane; Laila Benjilali; Lamiaa Essaadouni
Journal:  Pan Afr Med J       Date:  2021-03-18

7.  Novel case of an adult with toxic shock syndrome following COVID-19 infection.

Authors:  Yilin Feng; Stephen T Armenti; Owen R Albin; Shahzad I Mian
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-29

8.  Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.

Authors:  Can Chen; Kunming Pan; Bingjie Wu; Xiaoye Li; Zhangzhang Chen; Qing Xu; Xiaoyu Li; Qianzhou Lv
Journal:  Eur J Clin Pharmacol       Date:  2020-08-11       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.